Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BOSTON SCIENTIFIC CORPBSX · Entity 1897 | Director | October 01, 2020 | October 05, 2020 |
| ILLUMINA, INC.ILMN · Entity 3137 | Director | May 16, 2024 | May 17, 2024 |
| STRYKER CORPSYK · Entity 369 | President & CEO | February 06, 2012 | February 08, 2012 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BOSTON SCIENTIFIC CORP
Report date October 01, 2020 · Filed October 05, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,000 |
Reported balance
After 2020-10-01 transaction · row 1
1 source rowRow 1 · 2020-10-01 · Grant · Acquired 498 · Balance 8,000 F1: Restricted stock granted in lieu of cash compensation, vesting in full upon the next annual meeting of stockholders. Reflects a value of $19,167, divided by the closing price of common stock on the date of grant. This grant represents the equivalent of two months of the board cash retainer as a result of board approval of the restoration of a portion of its cash compensation as disclosed on a Form 8-K dated October 5, 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock granted in lieu of cash compensation, vesting in full upon the next annual meeting of stockholders. Reflects a value of $19,167, divided by the closing price of common stock on the date of grant. This grant represents the equivalent of two months of the board cash retainer as a result of board approval of the restoration of a portion of its cash compensation as disclosed on a Form 8-K dated October 5, 2020.
ILLUMINA, INC.
Report date May 16, 2024 · Filed May 17, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,129 |
Reported balance
After 2024-05-16 transaction · row 1
1 source rowRow 1 · 2024-05-16 · Grant · Acquired 2,622 · Balance 4,129 F1: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date.
STRYKER CORP
Report date February 06, 2012 · Filed February 08, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 132,002 |
Reported balance
After 2012-02-06 transaction · row 1
1 source rowRow 1 · 2012-02-06 · Exercise / conversion · Acquired 5,000 · Balance 132,002 |
| Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $46.85 · Expires 2016-02-06 | Direct | 0 |
Reported balance
After 2012-02-06 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2012-02-06 · Exercise / conversion · Disposed 5,000 · Balance 0 F1: Employee stock option granted pursuant to the Stryker Corporation 1998 Stock Option Plan, exercisable as to 10% on each of the first eight anniversaries of the date of grant and 20% on the ninth anniversary of the date of grant. |
| Common StockSEC Table I · non-derivative | IndirectBy 401k Plan | 716 |
Reported balance
Holding disclosure · report date 2012-02-06 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 716 |
| Common StockSEC Table I · non-derivative | IndirectAs Custodian | 200 |
Reported balance
Holding disclosure · report date 2012-02-06 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 200 |
Filing footnotes · ownership attribution and instrument terms
F1: Employee stock option granted pursuant to the Stryker Corporation 1998 Stock Option Plan, exercisable as to 10% on each of the first eight anniversaries of the date of grant and 20% on the ninth anniversary of the date of grant.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
HOLOGIC INC
Report date April 07, 2026 · Filed April 09, 2026
Section 16 reporting ended · disclosed 2026-04-09. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 1
1 source rowRow 1 · 2026-04-07 · Disposition to issuer · Disposed 1,423,837 · Balance 0 F1: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to Hologic's Deferred Equity Plan. F2: Pursuant to the Agreement and Plan of Merger, dated as of October 21, 2025 (the "Merger Agreement"), by and among Hologic, Inc. ("Hologic" or "Company"), Hopper Parent Inc., a Delaware corporation ("Parent"), and Hopper Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of Hologic common stock, par value $0.01 ("Company Common Stock"), was converted into the right to receive (x) $76.00 per share in cash, without interest (the "Cash Consideration") and (y) one (1) contingent value right, which represents the right to receive up to $3.00 in cash, when and if payable (each, a "CVR") (the consideration contemplated by clauses (x) and (y), together, the "Merger Consideration"). F3: At the Effective Time, each time-vesting restricted stock unit award ("Company RSU") held by the reporting person granted before October 21, 2025 converted into the right to receive the Merger Consideration for each share of Company Common Stock underlying the Company RSU; and each Company RSU held by the reporting person granted after October 21, 2025 converted into, for each share of Company Common Stock subject to such Company RSU immediately prior to the Effective Time, (i) an unvested award representing the right to receive a cash payment equal to the Cash Consideration, and (ii) an unvested award representing the right to receive cash payments equal to the payments to the holder of one CVR, if any, pursuant to the CVR agreement, in each case, subject to the terms applied to the corresponding Company RSU immediately prior to the Effective Time. As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock. |
| Common StockSEC Table I · non-derivative | IndirectMacMillan Family Trust | 0 |
Reported balance
After 2026-04-07 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-04-07 · Disposition to issuer · Disposed 1,146,829 · Balance 0 F2: Pursuant to the Agreement and Plan of Merger, dated as of October 21, 2025 (the "Merger Agreement"), by and among Hologic, Inc. ("Hologic" or "Company"), Hopper Parent Inc., a Delaware corporation ("Parent"), and Hopper Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of Hologic common stock, par value $0.01 ("Company Common Stock"), was converted into the right to receive (x) $76.00 per share in cash, without interest (the "Cash Consideration") and (y) one (1) contingent value right, which represents the right to receive up to $3.00 in cash, when and if payable (each, a "CVR") (the consideration contemplated by clauses (x) and (y), together, the "Merger Consideration"). F4: As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $37.64 · Expires 2026-12-01 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-04-07 · Disposition to issuer · Disposed 160,565 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $40.85 · Expires 2027-12-01 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-04-07 · Disposition to issuer · Disposed 159,339 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $40.85 · Expires 2027-12-01 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-04-07 · Disposition to issuer · Disposed 768,639 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $40.97 · Expires 2028-11-12 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-04-07 · Disposition to issuer · Disposed 151,071 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $45.61 · Expires 2029-11-11 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-04-07 · Disposition to issuer · Disposed 152,529 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $68.35 · Expires 2030-11-09 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-04-07 · Disposition to issuer · Disposed 123,801 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $71.13 · Expires 2031-11-08 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-04-07 · Disposition to issuer · Disposed 118,877 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $74.35 · Expires 2032-11-07 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2026-04-07 · Disposition to issuer · Disposed 106,300 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $71.94 · Expires 2033-11-14 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2026-04-07 · Disposition to issuer · Disposed 117,829 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $79.39 · Expires 2034-11-11 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2026-04-07 · Disposition to issuer · Disposed 117,801 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 190,400 |
Reported balance
After 2026-04-07 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2026-04-07 · Grant · Acquired 190,400 · Balance 190,400 F6: Each Hologic restricted stock unit represents a contingent right to receive one share of Company Common Stock. F7: Represents the certification of performance results applicable to outstanding Hologic performance stock units ("PSUs") by the compensation committee of the board of directors of Hologic. Pursuant to the Merger Agreement, for purposes of determining the number of shares of Company Common Stock subject to each PSU, any applicable performance goals were deemed achieved at the greater of (A) the target level of performance and (B) the actual level of performance measured through the latest practicable date prior to the Effective Time. Pursuant to the Merger Agreement, each outstanding PSU was cancelled and converted into the right to receive the Merger Consideration in respect of each share of Company Common Stock subject to such PSU. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2026-04-07 · Disposition to issuer · Disposed 190,400 · Balance 0 F6: Each Hologic restricted stock unit represents a contingent right to receive one share of Company Common Stock. F7: Represents the certification of performance results applicable to outstanding Hologic performance stock units ("PSUs") by the compensation committee of the board of directors of Hologic. Pursuant to the Merger Agreement, for purposes of determining the number of shares of Company Common Stock subject to each PSU, any applicable performance goals were deemed achieved at the greater of (A) the target level of performance and (B) the actual level of performance measured through the latest practicable date prior to the Effective Time. Pursuant to the Merger Agreement, each outstanding PSU was cancelled and converted into the right to receive the Merger Consideration in respect of each share of Company Common Stock subject to such PSU. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to Hologic's Deferred Equity Plan.
F2: Pursuant to the Agreement and Plan of Merger, dated as of October 21, 2025 (the "Merger Agreement"), by and among Hologic, Inc. ("Hologic" or "Company"), Hopper Parent Inc., a Delaware corporation ("Parent"), and Hopper Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of Hologic common stock, par value $0.01 ("Company Common Stock"), was converted into the right to receive (x) $76.00 per share in cash, without interest (the "Cash Consideration") and (y) one (1) contingent value right, which represents the right to receive up to $3.00 in cash, when and if payable (each, a "CVR") (the consideration contemplated by clauses (x) and (y), together, the "Merger Consideration").
F3: At the Effective Time, each time-vesting restricted stock unit award ("Company RSU") held by the reporting person granted before October 21, 2025 converted into the right to receive the Merger Consideration for each share of Company Common Stock underlying the Company RSU; and each Company RSU held by the reporting person granted after October 21, 2025 converted into, for each share of Company Common Stock subject to such Company RSU immediately prior to the Effective Time, (i) an unvested award representing the right to receive a cash payment equal to the Cash Consideration, and (ii) an unvested award representing the right to receive cash payments equal to the payments to the holder of one CVR, if any, pursuant to the CVR agreement, in each case, subject to the terms applied to the corresponding Company RSU immediately prior to the Effective Time. As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock.
F4: As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock.
F5: For Footnote (5), see Remarks below.
F6: Each Hologic restricted stock unit represents a contingent right to receive one share of Company Common Stock.
F7: Represents the certification of performance results applicable to outstanding Hologic performance stock units ("PSUs") by the compensation committee of the board of directors of Hologic. Pursuant to the Merger Agreement, for purposes of determining the number of shares of Company Common Stock subject to each PSU, any applicable performance goals were deemed achieved at the greater of (A) the target level of performance and (B) the actual level of performance measured through the latest practicable date prior to the Effective Time. Pursuant to the Merger Agreement, each outstanding PSU was cancelled and converted into the right to receive the Merger Consideration in respect of each share of Company Common Stock subject to such PSU.
TEXAS INSTRUMENTS INC
Report date February 17, 2012 · Filed February 21, 2012
Section 16 reporting ended · disclosed 2012-02-21. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $1.00 | Direct | 5,899.25 |
Reported balance
After 2012-02-17 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2012-02-17 · Grant · Acquired 98.3 · Balance 5,899.25 F1: Security converts to common stock on a one-for-one basis. F2: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. |
| Common StockSEC Table I · non-derivative | Direct | 13,977 |
Reported balance
Holding disclosure · report date 2012-02-17 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 13,977 |
Filing footnotes · ownership attribution and instrument terms
F1: Security converts to common stock on a one-for-one basis.
F2: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 21, 2010 Filed May 24, 2010 21:23 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 137.4 | $24.26 Strike: $1.00 | $3,333.32 |
DisclosureSEC source: 0001127602-10-015274 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,404.64 Underlying: Common Stock · 137.4 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · balance_after: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. Read SEC document |
| April 16, 2010 Filed Apr 16, 2010 20:52 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 123.5 | $26.99 Strike: $1.00 | $3,333.27 |
DisclosureSEC source: 0001127602-10-011268 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,251.56 Underlying: Common Stock · 123.5 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · balance_after: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. Read SEC document |
| March 19, 2010 Filed Mar 22, 2010 20:57 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 134.84 | $24.72 Strike: $1.00 | $3,333.24 |
DisclosureSEC source: 0001127602-10-009264 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,128.06 Underlying: Common Stock · 134.84 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · balance_after: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. Read SEC document |
| February 23, 2010 Filed Feb 25, 2010 11:54 UTC | STRYKER CORP SYK · Entity 369 | GrantCommon Stock · Derivative | 120,000 | $53.09 Strike: $53.09 | $6,370,800.00 |
DisclosureSEC source: 0000310764-10-000037 · edgar.xml · derivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2020-02-22 F1 · derivative.exercise_date: Stock option granted pursuant to the Stryker Corporation 2006 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| February 19, 2010 Filed Feb 19, 2010 22:29 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 134.25 | $24.83 Strike: $1.00 | $3,333.43 |
DisclosureSEC source: 0001127602-10-005653 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,979.56 Underlying: Common Stock · 134.25 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · balance_after: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. Read SEC document |
| January 28, 2010 Filed Feb 1, 2010 22:40 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantNQ Stock Option (Right to Buy) · Derivative | 7,000 | $0.00 Strike: $23.05 | $0.00 |
DisclosureSEC source: 0001127602-10-002908 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 7,000 shares Expires 2020-01-28 F2 · derivative.exercise_date: The option becomes exercisable in four equal annual installments beginning on January 28, 2011. Read SEC document |
| January 28, 2010 Filed Feb 1, 2010 22:40 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-002908 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 F1 · kind: Award of restricted stock units granted under the Texas Instruments 2009 Director Compensation Plan. Read SEC document |
| January 22, 2010 Filed Jan 26, 2010 14:46 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock · Derivative | 5,000 | $46.85 Strike: $46.85 | $234,250.00 |
DisclosureSEC source: 0000310764-10-000010 · edgar.xml · derivative · entry 4 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 985,000 Underlying: Common Stock · 5,000 shares Expires 2016-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 1998 Stock Option Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. F2 · balance_after: Options for 5,000 shares that became available in 2008 were forfeited by Mr. MacMillan because the market price was below the exercise price. Read SEC document |
| January 22, 2010 Filed Jan 26, 2010 14:46 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 5,000 | $46.85 | $234,250.00 |
DisclosureSEC source: 0000310764-10-000010 · edgar.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,002 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 15, 2010 Filed Jan 15, 2010 23:02 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 134.9 | $24.71 Strike: $1.00 | $3,333.38 |
DisclosureSEC source: 0001127602-10-001650 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,845.31 Underlying: Common Stock · 134.9 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. F2 · balance_after: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. Read SEC document |
| December 18, 2009 Filed Dec 18, 2009 22:47 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 132.91 | $25.08 Strike: $1.00 | $3,333.38 |
DisclosureSEC source: 0001127602-09-025725 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,710.41 Underlying: Common Stock · 132.91 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · balance_after: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. Read SEC document |
| November 20, 2009 Filed Nov 20, 2009 23:01 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 133.98 | $24.88 Strike: $1.00 | $3,333.42 |
DisclosureSEC source: 0001127602-09-023285 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,577.51 Underlying: Common Stock · 133.98 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · balance_after: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. Read SEC document |
| October 16, 2009 Filed Oct 19, 2009 20:41 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 143.37 | $23.25 Strike: $1.00 | $3,333.35 |
DisclosureSEC source: 0001127602-09-020893 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,432.06 Underlying: Common Stock · 143.37 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. F2 · balance_after: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. Read SEC document |
| September 18, 2009 Filed Sep 18, 2009 20:56 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 141.24 | $23.60 Strike: $1.00 | $3,333.26 |
DisclosureSEC source: 0001127602-09-019196 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,288.69 Underlying: Common Stock · 141.24 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. F2 · balance_after: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. Read SEC document |
| August 21, 2009 Filed Aug 25, 2009 21:31 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 138.26 | $24.11 Strike: $1.00 | $3,333.45 |
DisclosureSEC source: 0001127602-09-018003 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,147.45 Underlying: Common Stock · 138.26 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · balance_after: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. Read SEC document |
| July 17, 2009 Filed Jul 20, 2009 20:46 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 149.21 | $22.34 Strike: $1.00 | $3,333.35 |
DisclosureSEC source: 0001127602-09-015763 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000.01 Underlying: Common Stock · 149.21 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. F2 · balance_after: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. Read SEC document |
| June 19, 2009 Filed Jun 22, 2009 21:24 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 156.27 | $21.33 Strike: $1.00 | $3,333.24 |
DisclosureSEC source: 0001127602-09-014353 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,850.8 Underlying: Common Stock · 156.27 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · balance_after: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. Read SEC document |
| May 15, 2009 Filed May 18, 2009 21:34 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 190.04 | $17.54 Strike: $1.00 | $3,333.30 |
DisclosureSEC source: 0001127602-09-011779 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,685.2 Underlying: Common Stock · 190.04 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. F2 · balance_after: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. Read SEC document |
| April 17, 2009 Filed Apr 20, 2009 21:00 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 187.26 | $17.80 Strike: $1.00 | $3,333.23 |
DisclosureSEC source: 0001127602-09-009366 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,495.15 Underlying: Common Stock · 187.26 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. Read SEC document |
| March 20, 2009 Filed Mar 24, 2009 21:33 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 200.8 | $16.60 Strike: $1.00 | $3,333.28 |
DisclosureSEC source: 0001127602-09-007621 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,307.89 Underlying: Common Stock · 200.8 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2003 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2003 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. F2 · balance_after: Stock units credited under the Texas Instruments 2003 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. Read SEC document |
| February 20, 2009 Filed Feb 23, 2009 23:04 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 222.82 | $14.96 Strike: $1.00 | $3,333.39 |
DisclosureSEC source: 0001127602-09-004564 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,107.09 Underlying: Common Stock · 222.82 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2003 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2003 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · balance_after: Stock units credited under the Texas Instruments 2003 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. Read SEC document |
| February 10, 2009 Filed Feb 12, 2009 21:22 UTC | STRYKER CORP SYK · Entity 369 | GrantCommon Stock · Derivative | 150,000 | $42.00 Strike: $42.00 | $6,300,000.00 |
DisclosureSEC source: 0000310764-09-000026 · edgar.xml · derivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2019-02-09 F1 · derivative.exercise_date: Stock option granted pursuant to the Stryker Corporation 2006 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| January 29, 2009 Filed Jan 31, 2009 01:18 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantNQ Stock Option (Right to Buy) · Derivative | 7,000 | $0.00 Strike: $14.95 | $0.00 |
DisclosureSEC source: 0001127602-09-002114 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 7,000 shares Expires 2019-01-29 F2 · derivative.exercise_date: The option becomes exercisable in four equal annual installments beginning on January 29, 2010. Read SEC document |
| January 29, 2009 Filed Jan 31, 2009 01:18 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-002114 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,500 F1 · kind: Award of restricted stock units granted under the Texas Instruments 2003 Director Compensation Plan. Read SEC document |
| January 16, 2009 Filed Jan 16, 2009 23:12 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 229.25 | $14.54 Strike: $1.00 | $3,333.30 |
DisclosureSEC source: 0001127602-09-001326 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 878.71 Underlying: Common Stock · 229.25 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2003 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2003 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. F2 · balance_after: Stock units credited under the Texas Instruments 2003 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. Read SEC document |
| December 19, 2008 Filed Dec 19, 2008 21:37 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 221.34 | $15.06 Strike: $1.00 | $3,333.38 |
DisclosureSEC source: 0001127602-08-011599 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 649.46 Underlying: Common Stock · 221.34 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2003 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2003 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. F2 · balance_after: Stock units credited under the Texas Instruments 2003 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. Read SEC document |
| November 21, 2008 Filed Nov 24, 2008 21:57 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 237.76 | $14.02 Strike: $1.00 | $3,333.40 |
DisclosureSEC source: 0001127602-08-010027 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 428.12 Underlying: Common Stock · 237.76 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2003 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2003 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · balance_after: Stock units credited under the Texas Instruments 2003 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. Read SEC document |
| October 17, 2008 Filed Oct 20, 2008 20:48 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 189.07 | $17.63 Strike: $1.00 | $3,333.30 |
DisclosureSEC source: 0001127602-08-008363 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189.07 Underlying: Common Stock · 189.07 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2003 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2003 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. F2 · balance_after: Stock units credited under the Texas Instruments 2003 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. Read SEC document |
| September 18, 2008 Filed Sep 22, 2008 21:08 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | OtherCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-08-007173 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 F1 · kind: Award of restricted stock units granted under the Texas Instruments 2003 Director Compensation Plan. Read SEC document |
| February 04, 2008 Filed Feb 5, 2008 22:26 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock · Derivative | 5,000 | $46.85 Strike: $46.85 | $234,250.00 |
DisclosureSEC source: 0000310764-08-000010 · edgar.xml · derivative · entry 5 MACMILLAN STEPHEN P · CIK 0001239351 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2016-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 1998 Stock Option Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| February 04, 2008 Filed Feb 5, 2008 22:26 UTC | STRYKER CORP SYK · Entity 369 | Tax withholdingCommon Stock | 498 | $67.88 | $33,804.24 |
DisclosureSEC source: 0000310764-08-000010 · edgar.xml · nonDerivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,002 Read SEC document |
| February 04, 2008 Filed Feb 5, 2008 22:26 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 5,000 | $46.85 | $234,250.00 |
DisclosureSEC source: 0000310764-08-000010 · edgar.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2006 Filed Feb 9, 2006 15:48 UTC | STRYKER CORP syk · Entity 369 | GrantCommon Stock · Derivative | 1,000,000 | $46.85 Strike: $46.85 | $46,850,000.00 |
DisclosureSEC source: 0000310764-06-000015 · primary_doc.xml · derivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 1,000,000 shares Expires 2016-02-06 F1 · derivative.exercise_date: Stock option granted pursuant to the Stryker Corporation 1998 Stock Option Plan, exercisable as to 10% on each of the first eight anniversaries of the date of grant and the balance on the ninth anniversary. Read SEC document |
| October 21, 2005 Filed Oct 21, 2005 19:30 UTC | STRYKER CORP SYK · Entity 369 | PurchaseCommon Stock | 5,000 | $40.37 | $201,850.00 |
DisclosureSEC source: 0000310764-05-000035 · primary_doc.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,500 Read SEC document |
| October 21, 2005 Filed Oct 21, 2005 20:40 UTC Amendment | STRYKER CORP SYK · Entity 369 | PurchaseCommon Stock | 5,000 | $40.37 | $201,850.00 |
DisclosureSEC source: 0000310764-05-000036 · primary_doc.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,500 Read SEC document |
| April 22, 2005 Filed Apr 26, 2005 19:33 UTC | STRYKER CORP SYK · Entity 369 | GrantCommon Stock · Derivative | 150,000 | $48.27 Strike: $48.27 | $7,240,500.00 |
DisclosureSEC source: 0001181678-05-000012 · primary_doc.xml · derivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2015-04-21 F1 · derivative.exercise_date: Stock option granted under the Stryker Corporation 1998 Stock Option Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| August 06, 2004 Filed Aug 6, 2004 19:57 UTC | STRYKER CORP SYK · Entity 369 | PurchaseCommon Stock | 2,500 | $44.28 | $110,700.00 |
DisclosureSEC source: 0001239351-04-000015 · primary_doc.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,500 Read SEC document |
| March 05, 2004 Filed Mar 9, 2004 13:33 UTC | STRYKER CORP SYK · Entity 369 | GrantCommon Stock · Derivative | 50,000 | $90.42 Strike: $90.42 | $4,521,000.00 |
DisclosureSEC source: 0001239351-04-000002 · primary_doc.xml · derivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2014-03-04 F1 · derivative.exercise_date: Stock option granted pursuant to the Stryker Corporation 1998 Stock Option Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| February 05, 2004 Filed Feb 5, 2004 20:05 UTC | STRYKER CORP SYK · Entity 369 | PurchaseCommon Stock | 2,500 | $88.50 | $221,250.00 |
DisclosureSEC source: 0001239351-04-000001 · primary_doc.xml · nonDerivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,600 Read SEC document |
| February 05, 2004 Filed Feb 5, 2004 20:05 UTC | STRYKER CORP SYK · Entity 369 | PurchaseCommon Stock | 100 | $88.35 | $8,835.00 |
DisclosureSEC source: 0001239351-04-000001 · primary_doc.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · As Custodian Disclosed balance after: 100 Read SEC document |
| October 14, 2003 Filed Oct 16, 2003 21:43 UTC | STRYKER CORP SYK · Entity 369 | GrantCommon Stock · Derivative | 100,000 | $77.65 Strike: $77.65 | $7,765,000.00 |
DisclosureSEC source: 0001239351-03-000001 · primary_doc.xml · derivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2013-10-13 F1 · derivative.exercise_date: Stock option granted pursuant to the Stryker Corporation 1998 Stock Option Plan, exercisable as to 20% on each of the first five anniversary dates of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.